Page last updated: 2024-08-22

trimetazidine and Angina, Unstable

trimetazidine has been researched along with Angina, Unstable in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Han, L; Liu, J; Wang, B; Wang, C; Yao, D; Zhang, E; Zhang, P1
Challeton, JP; Correges, A; Danchin, N; Ferrari, R; Ford, I; Fox, K; Tendera, M; Widimský, P1
Jeong, KH; Kim, S; Kwon, J; Lee, E; Yu, YM1
Cui, W; Du, H; Hao, J; Li, WW; Liu, F; Lu, JC; Yang, XC; Zhao, ZF1
Ma, HJ; Qiu, ZX; Wang, DF1
Fragakis, N; Giannoglou, G; Katsaris, G; Labrou, A; Louridas, G; Zioutas, D1

Trials

4 trial(s) available for trimetazidine and Angina, Unstable

ArticleYear
Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
    Lancet (London, England), 2020, 09-19, Volume: 396, Issue:10254

    Topics: Administration, Oral; Africa, Northern; Aged; Angina, Stable; Angina, Unstable; Asia; Case-Control Studies; Coronary Angiography; Death; Europe; Female; Hospitalization; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Placebos; Recurrence; Safety; South America; Treatment Outcome; Trimetazidine; Vasodilator Agents

2020
Effects of atorvastatin combined with trimetazidine on myocardial injury and inflammatory mediator in unstable angina patients during perioperative of percutaneous coronary intervention.
    European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:23

    Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Combined Modality Therapy; Drug Therapy, Combination; Female; Heart Injuries; Humans; Inflammation Mediators; Interferon-gamma; Male; Middle Aged; Percutaneous Coronary Intervention; Perioperative Period; Postoperative Complications; Trimetazidine; Troponin I; Tumor Necrosis Factor-alpha

2015
[Observation on effect of compound danshen droplet-pill combined with trimetazidine in treating senile unstable angina pectoris].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2005, Volume: 25, Issue:9

    Topics: Aged; Aged, 80 and over; Angina, Unstable; Drug Administration Schedule; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Phenanthrolines; Phytotherapy; Salvia miltiorrhiza; Trimetazidine; Vasodilator Agents

2005
Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2007, Volume: 7, Issue:2

    Topics: Acute Disease; Administration, Oral; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Creatine Kinase, MB Form; Echocardiography; Female; Heart Ventricles; Humans; Hypokinesia; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardial Revascularization; Premedication; Syndrome; Trimetazidine; Troponin I; Vasodilator Agents; Ventricular Dysfunction, Left

2007

Other Studies

2 other study(ies) available for trimetazidine and Angina, Unstable

ArticleYear
Compound danshen dripping pills combined with trimetazidine in treating unstable angina pectoris: Protocol for a systematic review of randomized controlled trials.
    Medicine, 2019, Volume: 98, Issue:49

    Topics: Angina, Unstable; Camphanes; Drugs, Chinese Herbal; Humans; Panax notoginseng; Randomized Controlled Trials as Topic; Salvia miltiorrhiza; Systematic Reviews as Topic; Trimetazidine; Vasodilator Agents

2019
Association between Trimetazidine and Parkinsonism: A Population-Based Study.
    Neuroepidemiology, 2019, Volume: 52, Issue:3-4

    Topics: Adult; Aged; Angina, Unstable; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Parkinsonian Disorders; Population Surveillance; Republic of Korea; Trimetazidine; Vasodilator Agents

2019